Oncotarget mRNA COVID-19 Vaccination and Cancer Risk: A Case-Based Review The carcinogenic risk associated with these technologies, which has long been known within the gene... read more February 27, 2026
Oncotarget How HPV and COVID-19 Spike Proteins May Interact to Impact Cancer Suppression Thus, the present hypothesis is that virally encoded proteins such as HPV-E6 or SARS-COV-2 Spike... read more February 9, 2026
Oncotarget Exploring Possible Links Between COVID-19 Vaccination, Infection, and Cancer These findings underscore the need for rigorous epidemiologic, longitudinal, clinical, histopathological, forensic, and mechanistic studies... read more January 26, 2026
Oncotarget Overcoming Aromatase Inhibitor Resistance in Breast Cancer: A New Therapeutic Strategy The estrogen receptor is overexpressed in and promotes 67-80% and 90% of female and male... read more January 13, 2026
Oncotarget Comprehensive Genomic Profiling in Cancer: Insights from Over 10,000 Tumors The OncoExTra® assay (formerly GEM ExTra) is a whole exome, whole transcriptome, tumor-normal genomic profiling... read more December 15, 2025
Oncotarget Repurposing Statins: Exploring Anti-Tumor Effects in Colorectal Cancer Drug repurposing has gained traction as a viable strategy to target dysregulated oncogenic pathways."Colorectal... read more December 3, 2025
Oncotarget New Antibody Removes Tregs to Boost Immune Response Against Cancer Treg play a deleterious role in the tumor microenvironment by suppressing anti-tumor effector T cells."... read more November 19, 2025
Oncotarget How Low Oxygen Shields Prostate Cancer from Ferroptosis Therapies Preclinical and clinical studies indicate that ferroptosis suppresses tumor growth, and dysregulation of ferroptosis promotes... read more November 6, 2025
Oncotarget Genetic Study Identifies Potential Diagnostic Marker for Rare Blood Cancer BPDCN Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematological malignancy with poorly characterized molecular... read more October 22, 2025
Oncotarget New Insights into HER2-Mutated Non-Small Cell Lung Cancer in Brazil In non–small cell lung cancer (NSCLC), alterations in the HER2 (ERBB2) gene define a... read more October 8, 2025